Foundayo (Orforglipron) Foundayo is the latest addition to the oral GLP-1 roster, FDA-approved for weight loss in April 2026
Proteins tend to fold into complex three-dimensional shapes and bear multiple functions, while peptides are plain and usually operate via specific interactions
However, quantification of visceral adiposity did have independent clinical significance, because those with higher WHR had poorer exercise capacity and more severe kidney disease
Saloni Dattani: Tell us, tell me more about them
Trends in first-time prescribing First-time prescribing rates (first-time GLP-1 RA prescriptions per total prescriptions) in September 2025 are slightly decreased compared to June 2025 (-12.5%)
For multi-level involvement, the systemic effects of TB-500 become even more valuable, as it supports healing throughout the body rather than at a single site